Accelerator Awards support investigators pursuing ambitious four-year neuroendocrine cancer research to advance early detection, develop new therapies, and match treatments to individual tumor biology.
Investigator Awards - Neuroendocrine Tumor Research Foundation support researchers pursuing basic, translational, and select clinical studies to advance neuroendocrine cancer detection and treatment.
Pilot Awards - Neuroendocrine Tumor Research Foundation support researchers' pilot and feasibility studies of neuroendocrine cancers to advance early detection, new treatments, and personalized care.
NETRF Mentored Research Award supports early-career investigators with neuroendocrine cancer research funding and mentoring to advance early detection, new therapies, precision medicine, and research careers.
Acceleration Initiative Award supports researchers pursuing translational and preclinical pediatric cancer treatment research to overcome development barriers and reach clinical trials within three years.
Accelerating Hope: Clinical Trials for Hard-to-Treat Cancers Award supports researchers conducting clinical trials for hard-to-treat childhood cancers to advance safer, less toxic therapies.